Biparametric vs Multiparametric MRI for Prostate Cancer Diagnosis
Alexander Ng(Prostate Cancer Research), Enrique Gómez‐Gómez(Instituto Maimónides de Investigación Biomédica de Córdoba), Caroline M. Moore(University College London Hospitals NHS Foundation Trust), Fabian Falkenbach(Universität Hamburg), Daniel López-Ruiz(Hospital Universitario Reina Sofía), Valeria Panebianco(Sapienza University of Rome), Nathan Perlis(University of Toronto), Francesco De Cobelli(Vita-Salute San Raffaele University), Tristan Barrett(University of Cambridge), Gianluca Giannarini(Ospedale Santa Maria della Misericordia di Udine), Jim C. Hu(Presbyterian Hospital), Jeffrey J. Leow(Nanyang Technological University), Lars Budäus(Universität Hamburg), Ash Tewari(Royal Free London NHS Foundation Trust), Paras B. Singh(Royal Free London NHS Foundation Trust), Louise Dickinson(Royal Free London NHS Foundation Trust), Martina Pecoraro(Sapienza University of Rome), Francesco Giganti(University College Hospital), Sangeet Ghai(University Health Network), Arjun Nathan(British Association of Urological Surgeons), Raphaële Renard‐Penna(Sorbonne Université), Jan Philipp Radtke(Essen University Hospital), Giorgio Brembilla(Vita-Salute San Raffaele University), Veeru Kasivisvanathan(University College London Hospitals NHS Foundation Trust), Vinson Wai‐Shun Chan(Royal Free London NHS Foundation Trust), Caroline S. Clarke(The Royal Free Hospital), Shonit Punwani(Royal Free London NHS Foundation Trust), Christof Kastner(Cambridge University Hospitals NHS Foundation Trust), Ridhi Agarwal(University of Birmingham), Aiman Haider(University College London Hospitals NHS Foundation Trust), Samir S. Taneja(NYU Langone Health), Adriano Basso Dias(Royal Free London NHS Foundation Trust), Lance A. Mynderse(Mayo Clinic), Claudia Kesch(Essen University Hospital), Aqua Asif(Royal Free London NHS Foundation Trust), Rossano Girometti(University of Udine), Marimo Rossiter(Royal Free London NHS Foundation Trust), Pramit Khetrapal(Early Intervention Foundation), Mark Emberton(University College London), Lars Schimmöller(Universitätsklinik Marien Hospital Herne), M.A. Rodríguez Cabello(Hospital General de La Rioja), Lars Boesen(University of Copenhagen), Yemisi Takwoingi(NIHR Birmingham Biomedical Research Centre), Anita Mitra, Marcelo Borghi(Universidad de Buenos Aires), Clare Allen(St Peter's Hospital), Chris Brew‐Graves(Royal Free London NHS Foundation Trust), Daniel J. A. Margolis(Cornell University)
Cited by 44
Related Papers
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
|The Lancet|2017|3.2k
Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial
|Clinical Cancer Research|2017|635
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
|European Urology|2023|618
European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era
|European Urology|2020|313
METhodological RadiomICs Score (METRICS): a quality scoring tool for radiomics research endorsed by EuSoMII
|Insights into Imaging|2024|263